CoChat

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins

Open access
Reid, Patrick C., Urano, Yasuomi, Kodama, Tatsuhiko, Hamakubo, Takao · 2007 · Journal of Cellular and Molecular Medicine
Cited by 131

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Introduction Conclusions Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder and the most prevalent form of dementia worldwide. AD is characterized pathologically by amyloid‐β plaques, neurofibrillary tangles and neuronal loss, and clinically by a progressive loss of cognitive abilities. At present, the fundamental molecular mechanisms underlying the disease are unclear and no treatment for AD is known. Epidemiological evidence continues to mount linking vascular diseases, such as hypertension and diabetes, and hypercholesterolaemia with an increased risk for developing AD. A growing amount of evidence suggests a mechanistic link between cholesterol metabolism in the brain and the formation of amyloid plaques in AD development. Cholesterol and statins clearly modulate β‐amyloid precursor protein (βAPP) processing in cell culture and animal models. Statins not only reduce endogenous cholesterol synthesis but also exert other various pleiotrophic effects, such as the reduction in protein isoprenylation. Through these effects statins modulate a variety of cellular functions involving both cholesterol (and membrane rafts) and isoprenylation. Although clearly other factors, such as vascular inflammation, oxidative stress and genetic factors, are intimately linked with the progression of AD, this review focuses on the present research findings describing the effect of cholesterol, membrane rafts and isoprenylation in regulating βAPP processing and in particular γ‐secretase complex assembly and function and AD progression, along with consideration for the potential role statins may play in modulating these events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2007.00054.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 131

Metadata

Authors
Reid, P. C., Urano, Y., Kodama, T., & Hamakubo, T.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2007-05
Volume
11
Issue
3
Pages
383-392
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2095339554
Cited by
131
References
13
FWCI
12.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins. https://app.cochat.ai/papers/10.1111/j.1582-4934.2007.00054.x
The paper
Reid, P. C., Urano, Y., Kodama, T., & Hamakubo, T. (2007). Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2007.00054.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.